Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy

Blood (2019) 134 (Supplement_1): 185.

https://doi.org/10.1182/blood-2019-131390

Published: 2019

Journal Articles

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Hussain I Rangoonwala, MBBS, Jonathan Gootee, MD, Peter T. Silberstein, MD

Blood (2019) 134 (Supplement_1): 3840.

https://doi.org/10.1182/blood-2019-131233

Published: 2019

Journal Articles

Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide Therapy

Blood (2019) 134 (Supplement_1): 2638.

https://doi.org/10.1182/blood-2019-122120

Published: 2019

Journal Articles

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Blood (2019) 134 (Supplement_1): 2687.

https://doi.org/10.1182/blood-2019-131733

Published: 2019

Journal Articles

Treatment‐Related Acute Myeloid Leukemia in Children

Katharina Waack, Katharina Röllecke, PhD, Mareike Rasche, MD, Christiane Walter, MSc, Ursula Creutzig, MD PhD, Dirk Reinhardt, MD PhD

Blood (2019) 134 (Supplement_1): 1322.

https://doi.org/10.1182/blood-2019-131911

Published: 2019

Journal Articles

Integrated Analysis of Global DNA Methylation and Transcription Reveals a Leukemia Subtype with Extreme Hypermethylation Associated with Silencing of Regulators of Differentiation

Claudia Gebhard, PhD, Roger Mulet-Lazaro, B.Sc., Lucia Schwarzfischer, Dagmar Glatz, Margit Nuetzel, Daniel Heudobler, MD, Sandra Pohl, Wolfgang Herr, MD, Gerhard Ehninger, MD, Claudia Erpelinck-Verschueren, B.Sc., Stanley van Herk, B.Sc., B.J. Wouters, Christian Thiede, MD, Ruud Delwel, PhD, Michael Rehli, PhD

Blood (2018) 132 (Supplement 1): 2608.

https://doi.org/10.1182/blood-2018-99-118521

Published: 2018

Journal Articles

The Clinical and Biological Implications of Early Clearance of Peripheral Blood Blasts after Induction Chemotherapy in Acute Myeloid Leukemia

Ming-Kai Chuang, MD, Yu-Chiao Chiu, PhD, Hsin-An Hou, MD PhD, Wen-Chien Chou, MD, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 3991.

https://doi.org/10.1182/blood-2018-99-114071

Published: 2018

Journal Articles

Single-Cell Drug Profiling Reveals Maturation Stage-Dependent Drug Responses in AML

Heikki Kuusanmäki, MSc, Maija Leppä, BSc, Mika Kontro, MD, Olli Dufva, BSc, Debashish Deb, MSc, Bhagwan Yadav, PhD, Satu Mustjoki, MDPhD, Kimmo Porkka, MD PhD, Caroline A Heckman, PhD

Blood (2017) 130 (Supplement 1): 3821.

https://doi.org/10.1182/blood.V130.Suppl_1.3821.3821

Published: 2017

Journal Articles

Impact of FAB Classification on Predicting Outcome in Acute Myeloid Leukemia, Not Otherwise Specified, Patients Undergoing Allogeneic Stem Cell Transplantation in CR1: An Analysis of 1690 Patients from the Acute Leukemia Working Party of EBMT

Jonathan Canaani, MD, Eric Beohou, Myriam Labopin, Gerard Socie, MD PhD, Anne Huynh, MD, Liisa Volin, MD PhD, Jan J. Cornelissen, MD PhD, Noel Milpied, MD PhD, Tobias Gedde-Dahl, Eric Deconinck, MD PhD, Jeremy Delage, MD, Didier Blaise, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 2899.

https://doi.org/10.1182/blood.V128.22.2899.2899

Published: 2016

Journal Articles

Mutations of cMYC Exon 2 Are a Rare but Recurrent Abnormality in Adult Patients with Acute Myeloid Leukemia (AML)

Sylvia Herold, PhD, Michael Kramer, MSc., Christoph Röllig, MD, Matthias Kuhn, Thoralf Stange, Uwe Platzbecker, MD, Johannes Schetelig, MD M. Sc,, Hubert Serve, MD, Gerhard Ehninger, MD, Christian Thiede, MD

Blood (2015) 126 (23): 1408.

https://doi.org/10.1182/blood.V126.23.1408.1408

Published: 2015

Journal Articles

Higher Percentages of Ring Sideroblasts and SF3B1 Mutations in Patients with AML Correlate with Mutations in TP53 and Adverse Cytogenetics, but Have No Independent Impact on Outcome

Pedro Martin-Cabrera, MD, Sabine Jeromin, PhD, Tamara Alpermann, Karolína Perglerová, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 3847.

https://doi.org/10.1182/blood.V126.23.3847.3847

Published: 2015

Journal Articles

Integrative Analysis of Lincrna Expression and Clinical Annotations Reveals a Signature of 17 Genes with Prognostic Significance in Acute Myeloid Leukemia (AML)

Dominik Beck, PhD, Cintia Palu, MSc, Anushi Shah, PhD, Tobias Herold, MD, Jake Olivier, PhD, Peter J.M. Valk, PhD, Ruud Delwel, PhD, Stefan K Bohlander, MD, Jason W Wong, DPhil, John E Pimanda, MD PhD

Blood (2014) 124 (21): 483.

https://doi.org/10.1182/blood.V124.21.483.483

Published: 2014

Journal Articles

Specific Patterns of Molecular Mutations Determine the Morphologic Differentiation Stages in Acute Myeloid Leukemia (AML)

Dominic Rose, PhD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Karolina Perglerová, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2014) 124 (21): 2388.

https://doi.org/10.1182/blood.V124.21.2388.2388

Published: 2014

Journal Articles

Standard Proteomic Analysis (SPA) in AML: An Integrated Procedure for Discovering Hypoxia and Angiogenesis Patterns

Chenyue W Hu, Steven M. Kornblau, MD, Alex Bisberg, Amina A Qutub, PhD

Blood (2014) 124 (21): 1056.

https://doi.org/10.1182/blood.V124.21.1056.1056

Published: 2014

Journal Articles

A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE)

Blood (2013) 122 (21): 3967.

https://doi.org/10.1182/blood.V122.21.3967.3967

Published: 2013

Journal Articles

Acute Myeloid Leukemia With Isolated Trisomy 13 Is a Genetically Homogenous Entity With a High Frequency Of Mutations In Genes Encoding Components Of The Splicing Machinery and Extremely Poor Prognosis

Blood (2013) 122 (21): 608.

https://doi.org/10.1182/blood.V122.21.608.608

Published: 2013

Journal Articles

Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

Roland B. Walter, Megan Othus, Alan K. Burnett, Bob Löwenberg, Hagop M. Kantarjian, Gert J. Ossenkoppele, Robert K. Hills, Kees G. M. van Montfort, Farhad Ravandi, Anna Evans, Sherry R. Pierce, Frederick R. Appelbaum, Elihu H. Estey

Blood (2013) 121 (13): 2424–2431.

https://doi.org/10.1182/blood-2012-10-462440

Published: 2013

Includes: Supplemental data

Journal Articles

PHD Domain Deletion Mutations of ASXL1 Promote Myeloid Leukemia Transformation Through Epigenetic Dysregulation and Inhibit Megakaryocytic Differentiation Through the Inactivation of FOSB in K562 Cells.

Rabindranath Bera, PhD, Der-Cherng Liang, MD, Ming-Chun Chiu, Ying-Jung Huang, PhD, Sung-Tzu Liang, PhD, Lee-Yung Shih, MD

Blood (2012) 120 (21): 2393.

https://doi.org/10.1182/blood.V120.21.2393.2393

Published: 2012

Journal Articles

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

Tomasz Czerw, MD, Myriam Labopin, Norbert C. Gorin, MD, PhD, Sebastian Giebel, MD, Didier Blaise, MD, Giovanna Meloni, MD, Arnaud Pigneux, MD, PhD, Alberto Bosi, MD, Hendrik Veelken, MD PhD, Felicetto Ferrara, MD, Nicolaas Schaap, MD, PhD, Michele Baccarani, MD, Mohamad Mohty

Blood (2012) 120 (21): 3112.

https://doi.org/10.1182/blood.V120.21.3112.3112

Published: 2012

Journal Articles

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Sabine Jeromin, PhD, Ulrike Bacher, MD, Katharina Bayer, Frank Dicker, PhD, Christiane Eder, PhD, Annette Fasan, PhD, Vera Grossmann, MSc, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2012) 120 (21): 406.

https://doi.org/10.1182/blood.V120.21.406.406

Published: 2012

NARROW

Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy

Epidemiology and Survival Outcomes in Elderly Acute Myeloid Leukemia Patients: An NCDB Study

Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide Therapy

Altered Immunophenotypes on Leukemic and/or Monocytic Cells from Acute Myeloid Leukemia Highly Predict for Nucleophosmin Gene Mutation

Treatment‐Related Acute Myeloid Leukemia in Children

Integrated Analysis of Global DNA Methylation and Transcription Reveals a Leukemia Subtype with Extreme Hypermethylation Associated with Silencing of Regulators of Differentiation

The Clinical and Biological Implications of Early Clearance of Peripheral Blood Blasts after Induction Chemotherapy in Acute Myeloid Leukemia

Single-Cell Drug Profiling Reveals Maturation Stage-Dependent Drug Responses in AML

Impact of FAB Classification on Predicting Outcome in Acute Myeloid Leukemia, Not Otherwise Specified, Patients Undergoing Allogeneic Stem Cell Transplantation in CR1: An Analysis of 1690 Patients from the Acute Leukemia Working Party of EBMT

Mutations of cMYC Exon 2 Are a Rare but Recurrent Abnormality in Adult Patients with Acute Myeloid Leukemia (AML)

Higher Percentages of Ring Sideroblasts and SF3B1 Mutations in Patients with AML Correlate with Mutations in TP53 and Adverse Cytogenetics, but Have No Independent Impact on Outcome

Integrative Analysis of Lincrna Expression and Clinical Annotations Reveals a Signature of 17 Genes with Prognostic Significance in Acute Myeloid Leukemia (AML)

Specific Patterns of Molecular Mutations Determine the Morphologic Differentiation Stages in Acute Myeloid Leukemia (AML)

Standard Proteomic Analysis (SPA) in AML: An Integrated Procedure for Discovering Hypoxia and Angiogenesis Patterns

A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE)

Acute Myeloid Leukemia With Isolated Trisomy 13 Is a Genetically Homogenous Entity With a High Frequency Of Mutations In Genes Encoding Components Of The Splicing Machinery and Extremely Poor Prognosis

Significance of FAB subclassification of “acute myeloid leukemia, NOS” in the 2008 WHO classification: analysis of 5848 newly diagnosed patients

PHD Domain Deletion Mutations of ASXL1 Promote Myeloid Leukemia Transformation Through Epigenetic Dysregulation and Inhibit Megakaryocytic Differentiation Through the Inactivation of FOSB in K562 Cells.

Long-Term Follow-up of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML): A Survey of 3567 Patients From the Acute Leukemia Working Party of the EBMT.

SF3B1 Mutations Are Detectable in 48.9% of Acute Myeloid Leukemia with Normal Karyotype (AML-NK) and ≥15% Ring Sideroblasts and Are Closely Related to FLT3 -ITD and RUNX1 Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only